6th International Conference on Cardiology and Vascular Biology. London, UK. November 11-12, 2019
Conference Name: 6th International Conference on Cardiology and Vascular Biology
Conference date: November 11-12, 2019
Conference Venue: London, United Kingdom
Theme: Unraveling the plights in the field of cardio & vascular medicine
Description: Vascular Biology 2019 offers an enthusiastic opportunity for the growing generations occupied in various researches to improve their abilities in the field. It focuses on entailing several interactive scientific sessions that provide a benefit in learning Cardiology and Vascular Biology.
Website: https://vascular.cmesociety.com/
Related Articles:
 | Fast artificial intelligence for detecting the invisible Artificial Intelligence (AI) relies on synthetic neural networks, inspired by functional properties of living intelligent systems (brains) and learns autonomously on the basis of unsupervised learning procedures. Such learning permits,… |
 | UCLA researchers develop high-sensitivity… A significant advancement for point-of-care medical diagnostics, a team of researchers from UCLA has introduced a deep learning-enhanced, paper-based vertical flow assay (VFA) capable of detecting cardiac troponin I (cTnI)… |
 | T-cell subsets in HIV infection The human immunodeficiency virus (HIV) is a virus that assaults the body's immunologic system. If HIV is not tackled, it can eventually drive the organism to AIDS, which a dreadful… |
 | Cosmology in a cell: Defect annihilation in liquid crystals Topological defects are configurations of the order parameter which cannot be transformed continuously into a uniform state. They have been observed in various areas of physics, such as alloys, semiconductors,… |
 | Unlocking new treatments for bone diseases: using… Despite appearances, bones are a constantly changing organ in the body. Cells that produce new bone (named osteoblasts) and cells that break down bone (named osteoclasts) work in harmony to… |
 | Deep Molecular Profiling to understand the biology… Alzheimer disease (AD) is a complex, polygenic disease with genetic, cellular, pathologic, and clinical heterogeneity. Advances in high-throughput sequencing and omics technologies have accelerated the drive toward personalized medicine. Human… |
Leave a Reply
You must be logged in to post a comment.